FDA Clearance For ClearPoint Neuro Laser Device
The laser will be marketed as the ClearPoint Prism™ Neuro Laser Therapy System and is being hailed as a “new innovation in the space of laser interstitial thermal therapy”.
Laser ablation offers minimally-invasive and powerful treatments for a variety of neurological diseases.
- ClearPoint Neuro has exclusive global rights to commercialize the magnetic resonance guided laser interstitial thermal therapy system for neuro applications.
- The system is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy under 3.0T magnetic resonance imaging (MRI) guidance.
- The ClearPoint Neuro Navigation System has been used for over a decade in the United States and Europe to treat brain tumors, radiation necrosis and epileptic foci.
- ClearPoint continues to deliver innovation to the neurosurgery and spine community through its team and expert partners.
ClearPoint’s laser offers a number of exciting technical innovations that are expected to make laser interstitial thermal therapy simpler and more accessible to surgeons and their patients.